5,6-methylenedioxyanthranilic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并间二氧杂环戊烯类
• 英文名称: 5,6-methylenedioxyanthranilic acid
• 英文别名: 6-Amino-2,3-methylenedroxybenzoic acid；5-amino-1,3-benzodioxole-4-carboxylic acid
• 化学式: C₈H₇NO₄
• 分子量: 181.148
• InChiKey: WTNXAOYQSMDKPG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  81.8
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• [EN] FUSED-RING PYRIMIDIN-4(3H)-ONE DERIVATIVES, PROCESSES FOR THE PREPARATION AND USES THEREOF<br/>[FR] DERIVES DE LA PYRIMIDIN-4(3H)-ONE A CYCLES FUSIONNES, SPN PROCEDE DE PREPARATION ET SES UTILISATIONS
  申请人：SANKYO CO

  公开号：WO2003106435A1

  公开（公告）日：2003-12-24

  AbstractNovel compounds of the following formula (I) and pharmacologically acceptable salt and esters thereof can modulate LXR function and as a result show excellent anti-arteriosclerotic and anti-inflammatory activity:wherein:A represents aryl or heteroaryl;R1, R2 and R3 are the same or different and each represents hydrogen, hydroxyl, nitro, cyano, amino, halogen, carboxy, carbamoyl, mercapto, alkyl, haloalkyl, alkylcarbonyloxy, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, dialkylamino, alkylcarbonylamino, N-(alkylcarbonyl)-N-(alkyl)amino, alkoxycarbonylamino, N-(alkoxycarbonyl)-N-(alkyl)amino, alkylsulfonylamino, N-(alkylsulfonyl)-N-(alkyl)amino, haloalkylsulfonylamino, N-(haloalkylsulfonyl)-N-(alkyl)amino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl or dialkylaminocarbonyl group, or R1 and R2 together are alkylenedioxy;R4 and R5 are the same or different and each represents hydrogen, hydroxyl, amino, halogen, mercapto, alkyl, haloalkyl, alkoxy, alkoxycarbonyl or alkylthio;X represents hydrogen, hydroxyl, halogen, alkoxy or haloalkoxy; andY represents an optionally substituted alkyl, cycloalkyl, heterocyclyl, aryl, cycloalkylalkyl, heterocyclylalkyl or aralkyl group.

  新化合物具有以下式（I）的结构，其药学上可接受的盐和酯可以调节LXR功能，从而表现出优秀的抗动脉粥样硬化和抗炎活性：其中：A代表芳基或杂环芳基；R1、R2和R3相同或不同，每个代表氢、羟基、硝基、氰基、氨基、卤素、羧基、氨基甲酰基、巯基、烷基、卤代烷基、烷基羰氧基、烷氧基、烷硫基、烷磺基、烷基氨基、二烷基氨基、烷基羰基氨基、N-（烷基羰基）-N-（烷基）氨基、烷氧羰基氨基、N-（烷氧羰基）-N-（烷基）氨基、烷磺酰氨基、N-（烷磺酰基）-N-（烷基）氨基、卤代烷基磺酰氨基、N-（卤代烷基磺酰基）-N-（烷基）氨基、烷基羰基、烷氧羰基、烷基氨基羰基或二烷基氨基羰基，或R1和R2一起是亚烷二氧基；R4和R5相同或不同，每个代表氢、羟基、氨基、卤素、巯基、烷基、卤代烷基、烷氧基、烷氧羰基或烷硫基；X代表氢、羟基、卤素、烷氧基或卤代烷氧基；Y代表可选择取代的烷基、环烷基、杂环烷基、芳基、环烷基烷基、杂环烷基烷基或芳基烷基。
• NOVEL INSECTICIDES
  申请人：Hall Roger Graham

  公开号：US20100273830A1

  公开（公告）日：2010-10-28

  An insecticidal compound of formula (I) in which G 1 , G 2 , and G 3 together with the two carbon atoms to which G 1 and G 3 are attached, form a non-aromatic 4- or 5-membered ring system; wherein G 1 is sulfur, SO, SO 2 , oxygen, a direct bond, NR a or CR 5a R 5b ; G 2 is sulfur, SO, SO 2 , oxygen, a direct bond, NR b or CR 5c R 5d ; G 3 is sulfur, SO, SO 2 , oxygen, a direct bond, NR c or CR 5e R 5f ; with the provisos that a) not more than 1 group G can be a direct bond, b) not more than 2 G groups can be oxygen, sulfur, SO or SO 2 and c) when 2 G groups are oxygen, SO, SO 2 and/or sulfur the two groups are separated by a carbon atom; each of Z 1 and Z 2 , which may be the same or different, represents oxygen or sulfur; D is phenyl or a 5- or 6-membered heteroaromatic ring and R 1a , R 1b , R 5a , R 5b , R 5c , R 5d , R 5e , R 5f , R a , R b R c , R 2 , R 3 and R 20 are specified organic groups and agronomically acceptable salts/isomers/enantiomers/tautomers/N-oxides of those compounds.

  化合物(I)的杀虫剂化合物，其中G1、G2和G3与G1和G3连接的两个碳原子一起形成非芳香的4-或5-成员环系统；其中，G1是硫、SO、SO2、氧、直接键、NRa或CR5aR5b；G2是硫、SO、SO2、氧、直接键、NRb或CR5cR5d；G3是硫、SO、SO2、氧、直接键、NRc或CR5eR5f；具有以下规定：a）不超过1个基团G可以是直接键；b）不超过2个G基团可以是氧、硫、SO或SO2；c）当2个G基团是氧、SO、SO2和/或硫时，这两个基团之间由一个碳原子分隔；Z1和Z2中的每一个，可以相同也可以不同，代表氧或硫；D是苯或5-或6-成员杂芳环，R1a、R1b、R5a、R5b、R5c、R5d、R5e、R5f、Ra、RbRc、R2、R3和R20是指定的有机基团和农业上可接受的盐/异构体/对映体/互变异构体/氮氧化物。
• [EN] QUINOLINE DERIVATIVES<br/>[FR] DERIVES DE QUINOLINE
  申请人：ACTIVE BIOTECH AB

  公开号：WO2000003991A1

  公开（公告）日：2000-01-27

  The invention is related to compounds of general formula (I), wherein R is methyl, ethyl, n-propyl, iso-propyl, n-butyl or allyl; R' is methyl, methoxy, fluoro, chloro, bromo, trifluoromethyl, or OCHxFy, wherein x = O - 2, y = 1 - 3 with the proviso that x + y = 3; R'' is hydrogen, fluoro or chloro; with the proviso that R'' is fluoro or chloro only when R' is fluoro; R4 is hydrogen or pharmaceutically acceptable inorganic or organic cations; R5 is ethyl, n-propyl, iso-propyl, methoxy, ethoxy, chloro, bromo, trifluoromethyl, OCHxFy, or OCH2CHxFy wherein x = 0 - 2, y = 1 - 3 with the proviso that x + y = 3; R6 is hydrogen; or R5, and R6 taken together are methylenedioxy; and any tautomer thereof. The invention also relates to pharmaceutical compositions containing a compound of general formula (I) together with a pharmaceutically acceptable carrier. Included are also processes for the preparation of the compounds of formula (I), as well as methods for the treatment of mammals suffering from diseases resulting from autoimmunity and pathological inflammation by administering of a compound having formula (I) to said mammal.

  该发明涉及通式（I）的化合物，其中R为甲基，乙基，正丙基，异丙基，正丁基或烯丙基；R'为甲基，甲氧基，氟代，氯代，溴代，三氟甲基或OCHxFy，其中x = O-2，y = 1-3，但需满足x + y = 3；R''为氢，氟代或氯代；但需满足当R'为氟代时，R''仅为氟代或氯代；R4为氢或药学上可接受的无机或有机阳离子；R5为乙基，正丙基，异丙基，甲氧基，乙氧基，氯代，溴代，三氟甲基，OCHxFy或OCH2CHxFy，其中x = 0-2，y = 1-3，但需满足x + y = 3；R6为氢；或R5和R6一起为亚甲二氧基；以及其任何互变异构体。该发明还涉及含有通式（I）的化合物和药学上可接受的载体的制药组合物。还包括制备通式（I）化合物的方法，以及通过向哺乳动物施用具有通式（I）的化合物来治疗由自身免疫和病理性炎症引起的疾病的方法。
• Quinoline derivatives
  申请人：Active Biotech AB

  公开号：US20020173519A1

  公开（公告）日：2002-11-21

  Compounds of formula (I) 1 and tautomers thereof are effective for the treatment of mammals suffering from diseases resulting from autoimmunity and pathological inflammation.

  化合物式(I)1及其互变异构体对于治疗患有自身免疫和病理性炎症引起的疾病的哺乳动物是有效的。
• QUINOLINE DERIVATIVES
  申请人：Active Biotech AB

  公开号：EP1095021B1

  公开（公告）日：2003-09-17